Metronidazole-resistant Trichomonas vaginalis. 1979

A Forsgren, and L Forssman

A 36-year-old woman with symptomatic metronidazole-resistant trichomonal vaginitis for 10 years had a total of 22 courses of treatment with either metronidazole or tinidazole according to different schedules. The minimum trichomonicidal concentration of metronidazole for the strain of Trichomonas vaginalis isolated from the patient was 160 microgram/ml compared with 1.25-10 microgram/ml for other freshly isolated strains. The former strain also showed a definitely decreased sensitivity to ornidazole and tinidazole (80 microgram/ml). The mechanisms behind the appearance of resistance in this clinical isolate are at present unknown and require further study from the theoretical as well as the therapeutic viewpoint.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014011 Tinidazole A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections. Bioshik,CP-12,574,CP-12574,Fasigin,Fasigyn,Fasigyne,Fasygin,Simplotan,Tricolam,CP 12,574,CP 12574,CP12,574,CP12574
D014246 Trichomonas vaginalis A species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males. Trichomonas vaginali,vaginali, Trichomonas
D014247 Trichomonas Vaginitis Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS. Trichomoniasis, Human,Human Trichomoniases,Human Trichomoniasis,Trichomonas Vaginitides,Trichomoniases, Human,Vaginitides, Trichomonas,Vaginitis, Trichomonas

Related Publications

A Forsgren, and L Forssman
November 1981, Lancet (London, England),
A Forsgren, and L Forssman
January 1982, Lancet (London, England),
A Forsgren, and L Forssman
October 1993, The Medical journal of Australia,
A Forsgren, and L Forssman
December 2009, Sexual health,
A Forsgren, and L Forssman
March 1987, Obstetrics and gynecology,
A Forsgren, and L Forssman
January 1971, Vestnik dermatologii i venerologii,
A Forsgren, and L Forssman
September 1978, Lancet (London, England),
A Forsgren, and L Forssman
August 1980, Lancet (London, England),
A Forsgren, and L Forssman
September 1981, Lancet (London, England),
A Forsgren, and L Forssman
September 2016, International journal of STD & AIDS,
Copied contents to your clipboard!